Unraveling the kinetics and pharmacology of human PepT1 using solid supported membrane-based electrophysiology.

Biosensor High‐throughput screening (HTS) Membrane transport Peptide Transporter 1 (PepT1) Pharmacology Solid Supported Membrane-based Electrophysiology (SSME)

Journal

Bioelectrochemistry (Amsterdam, Netherlands)
ISSN: 1878-562X
Titre abrégé: Bioelectrochemistry
Pays: Netherlands
ID NLM: 100953583

Informations de publication

Date de publication:
Feb 2024
Historique:
received: 17 07 2023
revised: 14 09 2023
accepted: 15 09 2023
medline: 27 11 2023
pubmed: 26 9 2023
entrez: 25 9 2023
Statut: ppublish

Résumé

The human Peptide Transporter 1 (hPepT1) is known for its broad substrate specificity and its ability to transport (pro-)drugs. Here, we present an in-depth comprehensive study of hPepT1 and its interactions with various substrates via solid supported membrane-based electrophysiology (SSME). Using hPepT1-containing vesicles, we could not identify any peptide induced pre-steady-state currents, indicating that the recorded peak currents reflect steady-state transport. Electrogenic co-transport of H

Identifiants

pubmed: 37748262
pii: S1567-5394(23)00210-4
doi: 10.1016/j.bioelechem.2023.108573
pii:
doi:

Substances chimiques

Symporters 0
Peptide Transporter 1 0
Peptides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108573

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Authors AB, MB and NF are employed by Nanion Technologies GmbH, the developer of the SURFE(2)R instruments.

Auteurs

Alexander Körner (A)

Fraunhofer Institute for Cell Therapy and Immunology (IZI), Branch Bioanalytics and Bioprocesses (IZI-BB), Am Mühlenberg 13, 14476 Potsdam, Germany; Institute of Biotechnology, Technische Universität Berlin, Straße des 17. Juni 135, 10623 Berlin, Germany.

Andre Bazzone (A)

Nanion Technologies GmbH, Ganghoferstr. 70a, 80339 Munich, Germany.

Maximilian Wichert (M)

Fraunhofer Institute for Cell Therapy and Immunology (IZI), Branch Bioanalytics and Bioprocesses (IZI-BB), Am Mühlenberg 13, 14476 Potsdam, Germany; Freie Universität Berlin, Institute of Chemistry and Biochemistry - Biochemistry, 14195 Berlin, Germany.

Maria Barthmes (M)

Nanion Technologies GmbH, Ganghoferstr. 70a, 80339 Munich, Germany.

Srujan Kumar Dondapati (SK)

Fraunhofer Institute for Cell Therapy and Immunology (IZI), Branch Bioanalytics and Bioprocesses (IZI-BB), Am Mühlenberg 13, 14476 Potsdam, Germany. Electronic address: Srujan.Dondapati@izi-bb.fraunhofer.de.

Niels Fertig (N)

Nanion Technologies GmbH, Ganghoferstr. 70a, 80339 Munich, Germany.

Stefan Kubick (S)

Fraunhofer Institute for Cell Therapy and Immunology (IZI), Branch Bioanalytics and Bioprocesses (IZI-BB), Am Mühlenberg 13, 14476 Potsdam, Germany; Freie Universität Berlin, Institute of Chemistry and Biochemistry - Biochemistry, 14195 Berlin, Germany; Faculty of Health Sciences, Joint Faculty of the Brandenburg University of Technology Cottbus - Senftenberg, The Brandenburg Medical School Theodor Fontane and the University of Potsdam, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH